1. Home
  2. GDOT vs BBNX Comparison

GDOT vs BBNX Comparison

Compare GDOT & BBNX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Green Dot Corporation $0.001 par value

GDOT

Green Dot Corporation $0.001 par value

HOLD

Current Price

$11.65

Market Cap

642.1M

Sector

Finance

ML Signal

HOLD

Logo Beta Bionics Inc.

BBNX

Beta Bionics Inc.

HOLD

Current Price

$12.46

Market Cap

560.5M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
GDOT
BBNX
Founded
1999
2015
Country
United States
United States
Employees
N/A
423
Industry
Finance: Consumer Services
Medical/Dental Instruments
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
642.1M
560.5M
IPO Year
2010
N/A

Fundamental Metrics

Financial Performance
Metric
GDOT
BBNX
Price
$11.65
$12.46
Analyst Decision
Sell
Strong Buy
Analyst Count
2
11
Target Price
$11.00
$26.73
AVG Volume (30 Days)
586.8K
1.2M
Earning Date
01-01-0001
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
0.33
N/A
Revenue
$1,723,876,000.00
N/A
Revenue This Year
$22.56
$35.03
Revenue Next Year
$11.63
$33.24
P/E Ratio
$35.00
N/A
Revenue Growth
14.82
N/A
52 Week Low
$6.12
$8.89
52 Week High
$15.41
$32.71

Technical Indicators

Market Signals
Indicator
GDOT
BBNX
Relative Strength Index (RSI) 42.30 29.44
Support Level $11.43 $12.10
Resistance Level $11.83 $15.64
Average True Range (ATR) 0.30 1.02
MACD -0.01 0.30
Stochastic Oscillator 28.00 27.38

Price Performance

Historical Comparison
GDOT
BBNX

About GDOT Green Dot Corporation $0.001 par value

Green Dot Corp is a financial technology company that provides financial services for consumers in the United States without good banking options. It has three segments Consumer Services, Business to Business Services(B2B), and Money Movement Services. The company generates maximum revenue from B2B segment. Its B2B Services segment consists of revenues and expenses derived from (i) its partnerships with prominent consumer and technology companies that make banking products and services available to their consumers, partners and workforce through integration with its banking platform (the "Banking-as-a-Service", or "BaaS channel"), and (ii) a comprehensive payroll platform that it offers to corporate enterprises (the "Employer channel") to facilitate payments for today's workforce.

About BBNX Beta Bionics Inc.

Beta Bionics Inc is a commercial-stage medical device company engaged in the design, development, and commercialization of solutions to improve the health and quality of life of insulin-requiring people with diabetes (PWD) by utilizing adaptive closed-loop algorithms to simplify and improve the treatment of their disease. The company's product includes the iLet Bionic Pancreas (iLet). The company operates as a single segment, focused on the development, manufacture, and sale of the iLet.

Share on Social Networks: